Literature DB >> 7589991

Identification of a renal cell line that constitutively expresses the kidney-specific high-affinity H+/peptide cotransporter.

M Brandsch1, C Brandsch, P D Prasad, V Ganapathy, U Hopfer, F H Leibach.   

Abstract

In this study we describe for the first time the identification of a renal cell line that expresses the kidney-specific high-affinity H+/peptide cotransport system. The kidney cell line SKPT-0193 C1.2 was obtained by SV40 transformation of rat proximal tubular cells. The transport of the dipeptide glycylsarcosine (Gly-Sar) was studied in this cell line grown as a confluent monolayer on impermeable plastic supports. Uptake of the dipeptide was rapid and was stimulated sixfold by an inwardly directed H+ gradient, with optimal uptake occurring at an extracellular pH of 6.0. The uptake was markedly reduced by the protonophore carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone whether measured at pH 7.5 or 6.0. Intracellular acidification of the cells by NH4Cl prepulse also reduced the uptake of glycylsarcosine. The dipeptide uptake was found to be mediated by a high-affinity transport system with a Michaelis-Menten constant (Kt) of 67 +/- 2 microM and a maximal transport velocity of 1.20 +/- 0.02 nmol.10 min-1.mg protein-1. Studied over a concentration range of 5 microM to 5 mM, there was no evidence for a second saturable transport component. Di- and tripeptides, but not glycine, were strong inhibitors of glycylsarcosine uptake, indicating that these peptides also interact with the transport system with high affinity. Northern blot analysis of poly(A)+RNA from these cells using cDNA probes specific for the human intestinal peptide transporter (PEPT 1) or the human kidney-specific peptide transporter (PEPT 2) revealed that the transport system expressed in these cells is PEPT 2. It is concluded that the SKPT-0193 C1.2 cell line constitutively expresses the kidney-specific high-affinity H+/peptide cotransporter described in the proximal tubular epithelial cells of the normal kidney.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589991     DOI: 10.1096/fasebj.9.14.7589991

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

Review 2.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

3.  The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells.

Authors:  R Heidemann; C Zhang; H Qi; J Larrick Rule; C Rozales; S Park; S Chuppa; M Ray; J Michaels; K Konstantinov; D Naveh
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

Review 4.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Tubular localization and tissue distribution of peptide transporters in rat kidney.

Authors:  D E Smith; A Pavlova; U V Berger; M A Hediger; T Yang; Y G Huang; J B Schnermann
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

6.  Demonstration of functional dipeptide transport with expression of PEPT2 in guinea pig cardiomyocytes.

Authors:  Hua Lin; Nicola King
Journal:  Pflugers Arch       Date:  2006-11-21       Impact factor: 3.657

7.  Renal assimilation of short chain peptides: visualization of tubular peptide uptake.

Authors:  David A Groneberg; Frank Döring; Monika Nickolaus; Hannelore Daniel; Axel Fischer
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

8.  Transport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters.

Authors:  Dilara Jappar; Yongjun Hu; Richard F Keep; David E Smith
Journal:  Pharm Res       Date:  2008-09-27       Impact factor: 4.200

9.  Expression and function of SLC38A5, an amino acid-coupled Na+/H+ exchanger, in triple-negative breast cancer and its relevance to macropinocytosis.

Authors:  Sabarish Ramachandran; Souad R Sennoune; Monica Sharma; Muthusamy Thangaraju; Varshini V Suresh; Tyler Sneigowski; Yangzom D Bhutia; Kevin Pruitt; Vadivel Ganapathy
Journal:  Biochem J       Date:  2021-11-12       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.